Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ponatinib 45mg tablets
0801050BQAAABAB
|
Ponatinib | Ponatinib | Malignant Disease and Immunosuppression | No data available |
|
Porfimer sodium 15mg powder for solution for injection vials
0801050AHAAAAAA
|
Porfimer sodium | Porfimer sodium | Malignant Disease and Immunosuppression | No data available |
|
Porfimer sodium 75mg powder for solution for injection vials
0801050AHAAABAB
|
Porfimer sodium | Porfimer sodium | Malignant Disease and Immunosuppression | No data available |
|
Potactasol 1mg pdr for concentrate for inf vials
0801050AFBCAAAA
|
Potactasol | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Potactasol 4mg pdr for concentrate for inf vials
0801050AFBCABAB
|
Potactasol | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Prograf 5mg/1ml solution for infusion ampoules
0802020T0BBACAC
|
Prograf | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Proleukin 18million unit inj vials
0802040AQBBAAAA
|
Proleukin | Aldesleukin | Malignant Disease and Immunosuppression | No data available |
|
Prostap 3 Depot 11.25mg inj vials
0803042N0BBABAB
|
Prostap | Leuprorelin acetate | Malignant Disease and Immunosuppression | No data available |
|
Quizartinib 17.7mg tablets
0801050CTAAAAAA
|
Quizartinib | Quizartinib | Malignant Disease and Immunosuppression | No data available |
|
Quizartinib 26.5mg tablets
0801050CTAAABAB
|
Quizartinib | Quizartinib | Malignant Disease and Immunosuppression | No data available |
|
Raltitrexed 2mg powder for solution for infusion vials
0801030Z0AAAAAA
|
Raltitrexed | Raltitrexed | Malignant Disease and Immunosuppression | No data available |
|
Ramucirumab 100mg/10ml solution for infusion vials
0801050BZAAAAAA
|
Ramucirumab | Ramucirumab | Malignant Disease and Immunosuppression | No data available |
|
Ramucirumab 500mg/50ml solution for infusion vials
0801050BZAAABAB
|
Ramucirumab | Ramucirumab | Malignant Disease and Immunosuppression | No data available |
|
Razoxane 125mg tablets
0801050W0AAAAAA
|
Razoxane | Razoxane | Malignant Disease and Immunosuppression | No data available |
|
Rebif 22microg/0.5ml (6million units) inj pre-filled pens
0802040M0BBAJAM
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 22microg/0.5ml inj and Rebif 8.8microg/0.2ml inj
0802040M0BBALAQ
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 22microg/0.5ml inj and Rebif 8.8microg/0.2ml inj pfs
0802040M0BBAFAI
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 22micrograms/0.5ml (6million units) inj 1.5ml cart
0802040M0BBAGAJ
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 22micrograms/0.5ml (6million units) inj pfs
0802040M0BBADAF
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 44micrograms/0.5ml (12million units) inj 1.5ml cart
0802040M0BBAHAK
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 44micrograms/0.5ml (12million units) inj pf pens
0802040M0BBAKAN
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 44micrograms/0.5ml (12million units) inj pfs
0802040M0BBAEAG
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Rebif 8.8microg/0.1ml with 22microg/0.25ml initiation pack
0802040M0BBAIAL
|
Rebif | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Refolinon 30mg/10ml solution for injection ampoules
0801000I0BCACAF
|
Refolinon | Calcium folinate | Malignant Disease and Immunosuppression | No data available |
|
Regorafenib 40mg tablets
0801050BNAAAAAA
|
Regorafenib | Regorafenib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.